{
    "SentinusAI - Protein Design Engine": [
        // 抗體設計與優化
        "Therapeutic Antibody Design",
        "Antibody Discovery",
        "Antibody Humanization",
        "Affinity Maturation",
        "Epitope Mapping",
        "Immunogenicity Reduction",
        "Binding Specificity Optimization",
        "Off-target Toxicity Prediction",
        "Fab", "IgG", "VHH", "scFv",
        "ADC", "PDC", "Multi-specific Antibodies",

        // 蛋白質與酵素工程
        "Protein Engineering",
        "De Novo Proteian Design",
        "Protein Stability Optimization",
        "Developability Prediction",
        "Fusion Protein Engineering",
        "Enzyme Optimization",
        "Industrial Enzyme Design",
        "Biocatalyst Efficiency",
        "Catalytic Activity Enhancement",

        // 疫苗與抗原設計
        "Antigen Design",
        "Vaccine Development",
        "Vaccine Stability Enhancement",
        "Epitope Prediction",
        "mRNA Vaccine Optimization",

        // 核心功能技術
        "AI-Powered Protein Design",
        "Multi-objective Optimization",
        "Wet-lab Validated",
        "No Structure Required",
        "High-throughput Screening",
        "Toxicity Screening",
        "Therapeutic Protein Optimization",

        // 決策者職稱
        "Biopharma CTO",
        "VP of Protein Sciences",
        "Head of Biologics",
        "Director of Antibody Discovery",
        "Chief Scientific Officer",
        "Director of Protein Engineering",
        "VP of Biotherapeutics",
        "VP of Vaccine Development",
        "Director of Enzyme Engineering"
    ],
    "CellulaAI - Cell Programming AI Engine": [
        // 關鍵應用領域
        "Cell Therapy",
        "CAR-T",
        "NK Cell Therapy",
        "Stem Cell Therapy",
        "Regenerative Medicine",
        "Tissue Engineering",
        "Synthetic Biology",
        "Biomanufacturing",
        "Cell Line Development",
        "Cell Phenotype Optimization",
        "Cell Culture Scale-up",
        
        // 多組學與精準醫療
        "Multi-omics",
        "Genomics",
        "Transcriptomics",
        "Proteomics",
        "Biomarker Discovery",
        "Precision Medicine",
        "Patient Stratification",

        // AI 與自動化
        "AI-driven Predictive Modeling",
        "Automated Quality Control",
        "High-throughput Screening",
        "AI-powered Cell Engineering",
        "Wet-lab Validated",
        "Real-time Monitoring",
        "Scalable Automation",
        "Phenotypic Optimization",

        // 製造與法規
        "GMP Manufacturing",
        "Batch Consistency",
        "Process Optimization",
        "Regulatory Compliance",

        // 目標職位
        "Chief Scientific Officer",
        "VP of R&D",
        "Director of Cell Therapy",
        "Head of Biomanufacturing",
        "Head of Cell Engineering",
        "VP of Translational Medicine",
        "Director of Process Development",
        "Head of Stem Cell Platform",
        "Director of Precision Medicine"
    ],
    "CarbonAI - Small Molecule Design Engine": [
        // 核心技術與應用
        "Small Molecule Drug Discovery",
        "Lead Generation",
        "Lead Optimization",
        "De Novo Molecule Generation",
        "Scaffold Hopping",
        "Analog Expansion",
        "Molecular Docking",
        "Binding Pocket Detection",
        "Target Selectivity",
        "High-throughput Screening",
        "Polypharmacology",
        "Multi-target Drug Design",
        "AI-powered ADME Prediction",
        "Toxicity Prediction",
        "DMPK Modeling",
        "Drug-likeness Screening",
        "Reagent Property Prediction",
        "Physicochemical Optimization",
        
        // 領域/平台應用
        "PROTAC Design",
        "Protein Degradation",
        "CNS Drug Discovery",
        "Neurodegenerative Disease",
        "Kinase Inhibitor",
        "Hit-to-lead Workflow",
        
        // 潛在決策者職稱
        "VP Medicinal Chemistry",
        "DMPK Director",
        "Head of Pharmacology",
        "Director of Preclinical Development",
        "Chief Scientific Officer",
        "VP of Drug Discovery",
        "Head of Chemistry",
        "Lead Computational Chemist"
    ],
    "NatmolAI - Natural Molecule AI Engine": [
        "Natural Product Screening",
        "Nutraceutical R&D",
        "Traditional Medicine Innovation",
        "Green Chemistry Director"
    ],
    "SenseAI - RNA Design Engine": [
        // 關鍵 RNA 類型與治療策略
        "mRNA Therapeutics",
        "siRNA Drug Design",
        "mRNA Vaccine Design",
        "Protein Replacement Therapy",
        "RNA-based Therapies",
        "RNA Therapeutics",

        // 技術與功能（AI優化面）
        "Codon Optimization",
        "Codon Adaptation",
        "UTR Optimization",
        "5' UTR Design",
        "3' UTR Design",
        "Regulatory Element Prediction",
        "Sequence Stability Enhancement",
        "Chemical Modification of RNA",
        "Modified Base Prediction",
        "Immune Response Reduction",
        "Off-target Effect Minimization",
        "Inhibition Efficiency Evaluation",
        "AI-powered RNA Design",
        "Genome-wide Screening",
        "High-throughput RNA Optimization",
        "Expression Enhancement Models",
        "AI-driven Toxicity Prediction",

        // 特殊應用與挑戰
        "Rare Disease RNA Therapy",
        "Metabolic Disorder RNA Treatment",
        "RNA Vaccine Clinical Manufacturing",
        "siRNA Specificity Optimization",

        // 目標職位關鍵詞
        "VP RNA Biology",
        "Head of RNA Therapeutics",
        "Director of RNA Platform",
        "Chief Scientific Officer",
        "Director of mRNA Vaccine Development",
        "Head of Nucleic Acid Therapeutics",
        "VP Translational RNA Science"
    ],
    "BioSynthAI - Synthetic Biology Engine": [
        "Synthetic Biology Startup",
        "Metabolic Engineering Director",
        "Industrial Enzyme Company",
        "Fermentation Process Scientist"
    ]
}
